Press Release: Arisaph Pharmaceuticals : Research and Markets: Global Non Alcoholic Fatty Liver Disease (NAFLD) Pipeline Review 2015 - 18 Companies & 29 Drug Profiles

DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/b56vg5/non_alcoholic) has announced the addition of the "Non Alcoholic Fatty Liver Disease (NAFLD) - Pipeline Review, H2 2015" report to their offering. This report provides comprehensive information on the therapeutic development for Non Alcoholic Fatty Liver Disease (NAFLD), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of a